Contrave, Qsymia or Belviq: Which is the Best New FDA Approved Weight Loss Medication?: Unlocking the Brain’s Secrets to Permanent Weight Loss with the New FDA Approved Medications

Endocrinologist an weight loss specialist Richard Lipman M.D. has treated thousands of overweight and obese patients in his Miami Florida office. In this booklet he reviews three new, ground breaking weight loss medications released by the FDA over the past two years- Contrave, Qsymia and Belviq. He reviews the efficacy, safety, side effects and his experience treating hundreds of patients with these medications.
Dr Lipman points out that Americans have spent billions of dollars on weight loss plans and gym memberships over the past 20 years to fight the obesity epidemic without much success. Today, more than 70% of Americans are overweight and 35% are actually obese. Even when successful, 90% of dieters can only shed 10% of their excess weight with the best of plans. Making the task of weight maintenance even more frustrating is the fact that only 15% of dieters can keep their weight loss off for a year.
Recognizing these problems, pharmaceutical manufacturers have tried for years to produce medications to help the overweight individual lose and then maintain their weight loss without much success. Exaggerated claims, side effects and even severe medical complications have plagued the acceptance of weight loss drugs by both physicians and their overweight patients. The epidemic of increasing diabetes, hypertension and heart disease related to obesity has led physicians, drug manufacturers and even the FDA to search for new medications to help the overweight person lose and keep the weight off.
Recently, the FDA has approved three new weight loss medications: Contrave, Qsymia, and Belviq. Each of these medications are unique and attack the problems of hunger, cravings and weight gain by different mechanisms. These new medications are intended to help those who have tried everything, failing again and again to maintain their weight loss. They are for the millions with diabetes and other medical problems which have made their obesity impossible to reverse, and whose health is made worse by the extra weight. They are for those 100,000 or more Americans considering drastic action such as gastric bypass surgery. Contrave, Qsymia, and Belviq each have entirely different mechanisms of action, weight loss efficiency, and side effects, allowing you to individualize your weight loss experience by enhancing the benefits while minimizing the side effects. If you have 20, 30, 50, or even 100 pounds or more to lose, like 100 million other Americans, these medications may be for you. Dr Lipman reviews what would be the best choice of medications depending on your life style, weight, medical problems and eating patterns.

Click Here For More Information

Lose Weight with Belviq: No More Hunger with the Newest FDA Approved Weight Loss Medication

Belviq is the first new prescription drug for weight loss in the pass 20 years. Belviq was released by the FDA in early June 2013. It offers a new alternative for weight loss for the nearly one in three Americans who are considered obese. It is very effective in diabetics causing both weight loss and improvement in glucose control. Unlike any other diet medication it’s designed both for weight loss and weight maintenance

How does Belviq work?
The drug works by controlling appetite — specifically by activating brain receptors for serotonin, a neurotransmitter that triggers feelings of satiety and satisfaction. Serotonin is also involved in mood; many antidepressant drugs work by preventing the reuptake of serotonin and keeping brain receptors bathed in the chemical. Researchers at Arena say their drug is designed to seek out only the serotonin receptors that affect appetite.

How effective is Belviq?
According to clinical trial data submitted by Arena to the FDA, nearly half of dieters without Type 2 diabetes who used the medication lost at least 5% of their starting weight — or an average of 12 lbs. — over a year, compared with 23% of those taking a placebo. For best results, dieters are advised to use the medication together with a healthy diet and exercise program

Who can take Belviq?
The FDA approved the medication for people who are obese (with a body mass index, or BMI, of 30 or higher) or who are overweight (with a BMI of 27 or above) and also have at least one weight-related health condition such as type 2 diabetes, hypertension and high blood lipids and cholesterol.

Are there any side effects?
The most common side effects of Belviq in non-diabetic patients are headache, dizziness, fatigue, nausea, dry mouth and constipation. These side effects occurred in 6% or less patients and most disappeared after a few days. Only 6% of subjects pulled out of the Belviq studies because of side effect. In patients with diabetes, side effects include low blood sugar, headache, back pain, cough and fatigue.

Click Here For More Information